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Abstract
Background: Francisella tularensis is the causative agent of tularemia in humans and a large number of animal
species. Considering recent evidence of the circulation of this bacterium in different parts of Iran, especially in the
western provinces, the aim of current study was to determine the tularemia seroprevalence in the human
population living in Ilam Province.
Methods: In 2015, 360 serum samples were collected from five groups of people: ranchers (n = 112), farmers (n =
79), butchers and slaughterhouse workers (n = 61), Nature Conservation Officers (n = 34), and referents of medical
diagnostic laboratories (n = 74). These samples were tested for the presence of anti- F. tularensis IgG antibodies
using the ELISA method.
Results: According to the ELISA manufacturer cutoffs, we found that 10 (2.78%) and 9 (2.5%) sera, respectively,
were positive or borderline for F. tularensis IgG antibodies. The highest tularemia seroprevalence was observed
among farmers (7.59%).
Conclusions: Our results strongly support the circulation of tularemia in Ilam Province. Because no human
tularemia case has been reported so far in this province, we recommend specific education programs to increase
knowledge of local health care professionals about this important zoonotic disease.
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Background
Francisella tularensis is a Gram-negative, intracellular
bacterium, causing tularemia in humans and many ani-
mal species [1]. This pathogen is considered a biological
threat agent because it can induce severe diseases even
at a low infectious dose, it can be spread by aerosols, it
can survive for months in water and soil environments,
only a limited number of antibiotics can be used for
treatment, and no vaccine is available for prevention of
tularemia [2]. The species F. tularensis classically in-
cludes four subspecies: tularensis (type A), holarctica
(type B), mediasiatica and novicida. Only the two
former subspecies are considered causative agents of tu-
laremia in the world. Type A strains are mostly found in
North America. Type B strains are spread throughout
the northern hemisphere, and thus is the only subspecies
causing tularemia in Europe and Asia [3]. Type B strains
have been recently detected in Australia [4].
F. tularensis can infect many vertebrate and inverte-
brate animals. Small rodents and lagomorphs (rabbits
and hares) are considered the primary source of human
infections. Domestic animals (especially lambs and cats
in the United States) can occasionally be infected with
(or carriers of ) F. tularensis, and may transmit the dis-
ease to humans [2]. At-risk groups for tularemia include
laboratory staff, farmers, ranchers, hunters, veterinarians,
Nature Conservation Officers, butchers and slaughter-
house workers [5]. The routes of tularemia transmission
to humans are numerous: direct contact with infected ani-
mals (especially hares); consumption of F. tularensis-con-
taminated meat or water; arthropod bites (mainly ticks,
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and mosquitoes in specific areas); and exposure to a con-
taminated water or soil environment [1, 3, 6–8].
The clinical manifestations of tularemia in humans
vary from an asymptomatic infection to very severe dis-
eases, which may lead to death [9]. After a mean incuba-
tion period of 3–5 days, the disease begins often with
flu-like symptoms such as fever, chills, weakness, myal-
gia, joint pain, sore throats and headache. Then, depend-
ing on the route of infection, the disease may evolve to
one of six main clinical forms: glandular, ulceroglandu-
lar, oropharyngeal, oculoglandular, pneumonic, and ty-
phoidal [3]. Type A infections are usually more severe
than type B, and the mortality rates in untreated patients
are 10–40 and 1%, respectively [9].
In Iran, the first human tularemia case was reported in
1981 from the western part of the country (Kurdistan
province). The patient suffered from a glandular form of
tularemia, with fever, chills, myalgia, fatigue, headache,
anorexia and severe enlargement of the inguinal lymph
nodes [10]. Since then, no other tularemia case has been
reported in Iran [5]. Recent seroepidemiological studies,
however, have reported significant prevalence of anti-F.
tularensis antibodies in the Iranian population [11–13].
In a recent study, F. tularensis has been detected in rab-
bits and rodents in Iran by molecular methods [14]. On
the other hand, Turkey (a neighboring country in north-
western Iran), reported annually 400–2000 human
tularemia cases during the 2009–2012 period [8]. In fact,
very few recent studies have evaluated the status and
epidemiology of tularemia in Iran. The aim of the
current study was to investigate the tularemia seropreva-
lence among high-risk groups of individuals in the west-
ern province of Ilam.
Methods
Study area
This study was conducted in Ilam Province, western
Iran, in 2015 (Fig. 1). The province population is ap-
proximately 600,000, and it is located in a mountainous
region with a Mediterranean climate. This province
covers an area of 20,000 km2, about 1.2% of Iran.
Sampling
Blood samples were collected in three counties located
on the western part of Ilam Province: Ilam, Dehloran
and Mehran (Table 1). Patients included in the study
were over 18 years old and belonged to one of four at-
risk populations: ranchers, farmers, butchers and slaugh-
terhouse workers, and Nature Conservation Officers.
Referents of medical diagnostic laboratories (healthy
people without any clinical symptoms) from the same
area were selected as the control group. Informed con-
sent was obtained from all selected individuals. For each
participant, a 5 ml blood sample was taken and all
Fig. 1 Sampling site of Ilam Province in West of Iran to study tularemia infection, 2015
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samples transferred immediately to the laboratory for
serum extraction. Serum samples were then stored at −
20 °C. All sera were sent to the National Reference
Laboratory for Plague, Tularemia and Q fever in the Pas-
teur Institute of Iran for serological investigations.
Demographic and epidemiological data from people
included in the study were collected using two question-
naires. The demographic questionnaire included the
following information: age, sex, education, occupation,
marital status, county and place of residence. The second
questionnaire collected risk factors for F. tularensis expos-
ure: owning animals; hunting; consumption of meat from
wild animals; contact with a sick animal or its corpse; bites
from arthropods (ticks, fleas and mosquitoes); splashing
blood or other body fluids on the face or body; consump-
tion of non-pasteurized milk or dairy products; cutting
hands or other parts of the body during work with ani-
mals; use of personal protective equipment; and in general
knowledge of zoonosis and protective measures against
this infectious risk.
Serology
All sera were tested for the presence of F. tularensis IgG
antibodies using the commercial ELISA kit (Serion ELISA
classic Francisella tularensis, Virion/Serion GmbH, Würz-
burg, Germany) according to the manufacturer’s instruc-
tions. The retrieved ODs were evaluated according to the
protocols of Serion/Verion and the IgG was reported in a
quantitative way. The titer of IgG antibody was calculated
using a logistic- log model calculation in U/ml. Using cut-
off titers advocated by the manufacturer serological titers
were reported as positive (antibody titer > 15U/ml), bor-
derline (10–15U/ml), or negative (< 10U/ml).
Statistical analysis
The data was analyzed using Stata software version 11
(StataCorp, College Station, TX, USA). The potential
influence of tularemia risk factors on the observed sero-
prevalence rates was investigated by logistic regression
analysis. P-values less than 0.05 were considered statisti-
cally significant.
Results
We collected 360 serum samples from the five studied
groups, including ranchers (n = 112), farmers (n = 79),
butchers and slaughterhouse workers (n = 61), Nature
Conservation Officers (n = 34), and referents of medical
diagnostic laboratories (n = 74). Among these partici-
pants, 76.29% were males, 89.86% were married, and
45.18, 44.88 and 10.44% were living in urban, rural or
nomadic areas, respectively. The mean (± SD) age of the
tested subjects was 40.54 (±13.55) years old (range 18 to
78 years).
Of the 367 sera samples, 10 (2.78%) and 9 (2.5%) of
participants were considered positive or borderline for
anti-F. tularensis IgG antibodies, respectively. No
present or past history of tularemia could be recorded in
seropositive individuals. The highest and the lowest tu-
laremia seroprevalence were observed in farmers (7.59%)
and Nature Conservation Officers (0%), respectively
(Table 2). Seroprevalence was almost the same in all the
studied counties and in both genders. The age 31–40
years and over 50 years old had the highest and lowest
seroprevalence, respectively. None of the investigated
risk factors had a statistically significant relationship
with tularemia seroposivity (Table 3).
Discussion
Our study strongly supports the presence of tularemia in
Ilam Province. The overall tularemia seroprevalence
among different populations studied was 2.78%, although
we found a seroprevalence of 7.59% in farmers, which
are probably more exposed to the F. tularensis animal
reservoir. A much higher seroprevalence (14.7%) was
previously reported in Kurdistan Province, western Iran
[12]. A seroprevalence of 6.5% was also found in
butchers and slaughterhouse workers in the Sistan and
Baluchestan province, southeast of Iran [13].
The prevalence of tularemia in different parts of the
world is highly dependent on people culture and life-
style, although ecological conditions have an irrefutable
role [15–17]. In Iran, the highest prevalence of tularemia
has been observed among hunters (18%), and contact
with wildlife has been shown to be a significant risk fac-
tor [12]. In the present study, there was no statistically
significant relationship between tularemia seropreva-
lence and hunting or eating meat from wildlife animals.
A rarer practice of hunting in the province of Ilam com-
pared to other provinces of Iran may be one of the rea-
sons for lower exposure to F. tularensis and lower
tularemia seroprevalence.
Living in rural areas is usually considered a major risk
factor for tularemia because of more frequent contact
with wildlife animals [18, 19]. However, we found only
weak difference of seroprevalence between rural and
urban people of the study (3.77% versus 2.53%, NS).
Similar studies in Iranian Kurdistan [12] and Turkey
[20] have also reported non-significant differences be-
tween rural and urban populations. This probably means
Table 1 Population of the sampling sites of the studied areas in
Ilam Province, western Ilam
Area of residence
County Population Urban Rural Nomads No. of samples
Ilam 235,144 199,861 35,230 53 141
Dehloran 65,630 41,183 24,396 51 100
Mehran 29,797 19,186 10,516 95 118
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that people living in urban areas keep frequent contact
with the rural environment. As in other studies [12, 13,
18], gender was not associated with a significant differ-
ence in tularemia seroprevalence. More surprisingly, a
higher age was not associated with a higher seropreva-
lence of tularemia in our present study, while previous
ones have shown a higher seroprevalence in older people
[12, 18]. A possible explanation could be that tularemia
has been reintroduced recently in Ilam Province, and
thus middle-aged people, most at risk of tularemia, have
higher seroprevalence.
Tularemia prevalence also depends on the main reser-
voirs and modes of transmission of F. tularensis to
humans and animals. Several studies in Turkey have
shown that tularemia outbreaks have occurred in recent
years because of the consumption of contaminated
water. A water-borne tularemia infection usually con-
cerns a large population, of all ages, and all year round.
Water sources are usually contaminated by the wildlife
reservoir, including small rodents that are carriers of or
infected by F. tularensis. The role of migratory birds has
also been taken into consideration, because their
respiratory secretions and feces can cause water contam-
ination [21, 22]. Tularemia outbreaks have never been
reported in Iran, which is not in favor of extensive water
reservoir of tularemia. The role of ticks in the transmis-
sion of tularemia should be further evaluated as this
mode of transmission is highly prevalent in most tular-
emia endemic countries.
Finally, the absence of any statistically significant risk
factors in our study may be related to the small number
of seropositive participants (10 out of 367 studied indi-
viduals). Therefore, it is recommended that the number
of participants be higher in similar studies in areas with
low tularemia seroprevalence.
Although we found anti-F. tularensis antibodies in sev-
eral serum samples, no clinical case of tularemia has
been reported so far in Ilam Province. The Serion ELISA
method for detection of IgG antibodies directed against
F. tularensis antigen is considered highly sensitive and
specific [23]. Thus, our results highly suggest that tular-
emia is underdiagnosed in Ilam Province. F. tularensis
strains circulating in Iran should probably be of type B
as in the rest of Asia [1]. Type B strains usually cause
Table 2 Results from the bivariate logistic regression analysis of demographic predictors of tularemia using unadjusted odds ratios
(ORs)
Variable Category Number (% Positive Test) Crude OR (95% CI) P-Value
Occupation Referents of the medical diagnostic labs 74(1.35) 1.00
Rancher 112(0.89) 0.67 (0.02–26.34) 0.802
Butcher 61(3.28) 2.49 (0.19–74.92) 0.510
Nature Conservation Officers 34(0.00) 0.0 (0.00–41.91) 0.688
Farmer 79(7.59) 6.02 (0.86–142.6) 0.075
Gender Male 275(2.91) 1.00
Female 85(2.35) 0.80(0.11–3.56) 0.84
Age (Year) 18–30 101(1.98) 1.00
31–40 97(5.15) 2.68(0.51–20.35) 0.259
41–50 80(2.50) 1.27(0.13–12.4) 0.826
> 50 81(1.23) 0.63(0.02–8.38) 0.759
Area of residence Urban 158(2.53) 1.00
Rural 159(3.77) 1.51(0.41–6.16) 0.549
Nomads 39(0.00) 0.0(0.0–4.55) 0.411
Education Illiterate 81(2.47) 1.00
Primary 76(6.58) 2.76(0.53–21.13) 0.245
Secondary 46(4.35) 1.79(0.18–17.66) 0.594
Diploma 92(1.09) 0.44(0.01–5.82) 0.553
Academic 63(0.00) 0.25(0.01–5.31) 0.314
Marriage Single 36(5.56) 1.00
Married 324(2.47) 2.31 (0.32–10.5) 0.331
County Dehloran 100(3.00) 1.00
Mehran 118(2.54) 0.85(0.14–5.03) 0.849
Ilam 141(2.84) 0.95(0.19–5.17) 0.933
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infections of mild to moderate severity that can remained
undiagnosed [18, 24]. On the other hand, very low atten-
tion has been paid to tularemia in training programs for
physicians in Iran, and laboratories capable of confirming
tularemia cases have only existed for a few years in Iran. It
may be assumed that some tularemia patients have been
treated blindly with antibiotics [12]. Therefore, failure to
report human tularemia cases in Ilam Province is partly
justifiable and does not necessarily mean that the disease
is absent.
According to the high prevalence of tularemia in the
neighboring countries of Iran, including Azerbaijan [18],
Armenia [25] and Turkey [26], and the high tularemia
seroprevalence we found in the present and in previous
studies, there is a high potential for human infections
with F. tularensis occurring in different parts throughout
the country. Therefore, tularemia should be considered
as a differential diagnosis in patients suffering from
infectious diseases that have compatible clinical manifes-
tations. Continuous monitoring of the presence of this
bacterium should be carried out in different parts
throughout Iran. Furthermore, to identify the potential
reservoirs of F. tularensis, studies should be conducted
to isolate this bacterium from various sources such as
water and wild rodents.
One of the limitations of this study was the lack of an
appropriate occupational group representing the general
population. Referents of medical diagnostic labs were se-
lected as the control group because of the possibility of
taking blood samples from them. However, they may not
be a representative sample of the general population.
Nonetheless, the non-significant difference in the tular-
emia seroprevalence observed in this group compared to
the other occupational groups may indicate that risk of
exposure to F. tularensis in Ilam Province is unrelated to
professional activities. Also, although the ELISA method
Table 3 Relationship between behavioral characteristics and tularemia seropositivity in Ilam Province, 2015
Variable Number having the variable
(%Seropositive)




Attitudea 245(2.86) 113(2.65) 0.885
Splashing animal fluids on face/body 202(2.97) 99(3.03) 0.951
Exposure to ill or dying animals 86(0.00) 274(3.65) 0.063
Hunting/consumption of wild animal meat 228(3.95) 130(0.77) 0.148
Rabbit 8(0.00) 115(0.87) 0.935
Partridge 94(1.06) 29(0.00) 0.764
Fox 1(0.00) 124(0.81) 0.992
Mongoose 2(0.00) 121(0.83) 0.984
Emigrant/feral Birds 44(0.00) 79(1.27) 0.642
Mountain animals 88(1.14) 35(0.00) 0.715
Others** 3(0.00) 121(0.83) 0.976
Keeping animals 217(2.76) 139(2.88) 0.937
Cattle 77(3.90) 143(2.10) 0.466
Goats and sheep 197(2.54) 23(4.35) 0.610
Dogs and cats 100(2.00) 119(2.52) 0.832
Rabbit 8(0.00) 212(2.83) 0.799
Horse / Donkey 60(3.33) 160(3.12) 0.522
Hunting Meat Consumption (5 times or
more)
21(0.00) 98(2.02) 0.677
Unpasteurized milk and dairy 179(2.23) 179(3.35) 0.544
Mosquito bites 247(2.83) 107(2.80) 0.865
Tick bites 32(0.00) 322(3.11) 0.383
Flea bites 42(0.00) 311(3.22) 0.277
Using disinfection tools 74(1.35) 81(1.23) 0.955
Disinfection of hands/face 75(1.33) 80(1.25) 0.961
Length of employment (20 years or more) 129(2.33) 154(4.55) 0.339
Cutting hand/year (5 times or more) 17(5.88) 226(3.54) 0.621
aSee themselves as high risk for Zoonosis diseases
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has a high sensitivity and specificity for detection of
anti-F. tularensis antibodies and this test has been previ-
ously used for seroepidemiological studies, other methods
such as western blot, culture and PCR tests are required
to confirm tularemia diagnosis [27, 28].
Conclusions
Based on results of the present study and previous litera-
ture [5, 29, 30], tularemia is probably endemic in Iran.
Further studies are needed to confirm the occurrence of
human tularemia cases and evaluate their true incidence
in Iran. Physicians and other health care professionals
must be further sensitized about this zoonotic risk to
achieve this goal.
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